NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine -- causing sharp ...

Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made ...

The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. This means that if you are ...

Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...

If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...

The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...

Moderna (NASDAQ:MRNA) announced on Saturday that the U.S. Food and Drug Administration (FDA) approved its next-gen COVID-19 ...

The Covid-19 vaccine remains on the CDC's revised schedule of childhood vaccinations despite HHS Secretary Robert F. Kennedy ...